63 related articles for article (PubMed ID: 38551765)
1. Extracellular vesicles secreted by highly metastatic clonal variants of osteosarcoma preferentially localize to the lungs and induce metastatic behaviour in poorly metastatic clones.
Macklin R; Wang H; Loo D; Martin S; Cumming A; Cai N; Lane R; Ponce NS; Topkas E; Inder K; Saunders NA; Endo-Munoz L
Oncotarget; 2016 Jul; 7(28):43570-43587. PubMed ID: 27259278
[TBL] [Abstract][Full Text] [Related]
2. Investigation of cellular communication and signaling pathways in tumor microenvironment for high TP53-expressing osteosarcoma cells through single-cell RNA sequencing.
Xiong K; Fang Y; Qiu B; Chen C; Huang N; Liang F; Huang C; Lu T; Zheng L; Zhao J; Zhu B
Med Oncol; 2024 Mar; 41(5):93. PubMed ID: 38526643
[TBL] [Abstract][Full Text] [Related]
3. Intrinsic epigenetic state of primary osteosarcoma drives metastasis.
Singh I; Rainusso N; Kurenbekova L; Nirala BK; Dou J; Muruganandham A; Yustein JT
Mol Cancer Res; 2024 Jun; ():. PubMed ID: 38842581
[TBL] [Abstract][Full Text] [Related]
4. Mapping the Single-cell Differentiation Landscape of Osteosarcoma.
Truong DD; Weistuch C; Murgas KA; Deasy JO; Mikos AG; Tannenbaum A; Ludwig J
bioRxiv; 2023 Sep; ():. PubMed ID: 37745374
[TBL] [Abstract][Full Text] [Related]
5. The Fas/FasL Signaling Pathway: Its Role in the Metastatic Process and as a Target for Treating Osteosarcoma Lung Metastases.
Koshkina N; Yang Y; Kleinerman ES
Adv Exp Med Biol; 2020; 1258():177-187. PubMed ID: 32767242
[TBL] [Abstract][Full Text] [Related]
6. Participation of the Fas/FasL signaling pathway and the lung microenvironment in the development of osteosarcoma lung metastases.
Huang G; Nishimoto K; Yang Y; Kleinerman ES
Adv Exp Med Biol; 2014; 804():203-17. PubMed ID: 24924176
[TBL] [Abstract][Full Text] [Related]
7. Osteosarcoma cells exhibit functional interactions with stromal cells, fostering a lung microenvironment conducive to the establishment of metastatic tumor cells.
Valenzuela Alvarez MJP; Gutierrez LM; Bayo JM; Cantero MJ; Garcia MG; Bolontrade MF
Mol Biol Rep; 2024 Mar; 51(1):467. PubMed ID: 38551765
[TBL] [Abstract][Full Text] [Related]
8. Acquisition of stem associated-features on metastatic osteosarcoma cells and their functional effects on mesenchymal stem cells.
Álvarez MV; Gutiérrez LM; Auzmendi J; Correa A; Lazarowski A; Bolontrade MF
Biochim Biophys Acta Gen Subj; 2020 Apr; 1864(4):129522. PubMed ID: 31945406
[TBL] [Abstract][Full Text] [Related]
9. Mesenchymal Stem/Stromal Cells under Stress Increase Osteosarcoma Migration and Apoptosis Resistance via Extracellular Vesicle Mediated Communication.
Vallabhaneni KC; Hassler MY; Abraham A; Whitt J; Mo YY; Atfi A; Pochampally R
PLoS One; 2016; 11(11):e0166027. PubMed ID: 27812189
[TBL] [Abstract][Full Text] [Related]
10. Lung cells support osteosarcoma cell migration and survival.
Yu S; Fourman MS; Mahjoub A; Mandell JB; Crasto JA; Greco NG; Weiss KR
BMC Cancer; 2017 Jan; 17(1):78. PubMed ID: 28122543
[TBL] [Abstract][Full Text] [Related]
11. Unveiling the role of osteosarcoma-derived secretome in premetastatic lung remodelling.
Almeida SFF; Santos L; Sampaio-Ribeiro G; Ferreira HRS; Lima N; Caetano R; Abreu M; Zuzarte M; Ribeiro AS; Paiva A; Martins-Marques T; Teixeira P; Almeida R; Casanova JM; Girão H; Abrunhosa AJ; Gomes CM
J Exp Clin Cancer Res; 2023 Nov; 42(1):328. PubMed ID: 38031171
[TBL] [Abstract][Full Text] [Related]
12. Tumor-Activated Mesenchymal Stromal Cells Promote Osteosarcoma Stemness and Migratory Potential via IL-6 Secretion.
Cortini M; Massa A; Avnet S; Bonuccelli G; Baldini N
PLoS One; 2016; 11(11):e0166500. PubMed ID: 27851822
[TBL] [Abstract][Full Text] [Related]
13. Cancer metastasis: Molecular mechanisms and clinical perspectives.
Khan SU; Fatima K; Malik F; Kalkavan H; Wani A
Pharmacol Ther; 2023 Oct; 250():108522. PubMed ID: 37661054
[TBL] [Abstract][Full Text] [Related]
14. Prognostic role of the immunohistochemical expression of proteins related to the renin-angiotensin system pathway in nonmetastatic clear cell renal cell carcinoma.
Mourão TC; Bezerra SM; de Almeida E Paula F; Rocha MM; Santos VE; Brazão Junior ES; Abreu D; da Costa WH; Zequi SC
Urol Oncol; 2023 Aug; 41(8):359.e1-359.e13. PubMed ID: 37286405
[TBL] [Abstract][Full Text] [Related]
15. Activated fibroblasts in cancer: Perspectives and challenges.
Caligiuri G; Tuveson DA
Cancer Cell; 2023 Mar; 41(3):434-449. PubMed ID: 36917949
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]